Drugs that contain Vandetanib

1. List of Caprelsa drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE42353 GENZYME CORP Quinazoline derivatives and pharmaceutical compositions containing them
Jun, 2022

(7 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8642608 GENZYME CORP Quinazoline derivatives as VEGF inhibitors
Feb, 2022

(1 year, 3 days ago)

US8067427 GENZYME CORP Pharmaceutical compositions comprising ZD6474
Aug, 2028

(5 years from now)

Market Authorisation Date: 06 April, 2011

Treatment: For use in patients having symptomatic or progressive medullary thyroid cancer, with unresectable locally advanced or metastatic disease

Dosage: TABLET;ORAL

More Information on Dosage

CAPRELSA family patents

10

United States

5

European Union

4

Korea, Republic of

3

Austria

3

Hong Kong

3

Brazil

3

Spain

3

Germany

3

Slovenia

3

United Kingdom

3

Argentina

3

Portugal

3

China

3

Norway

3

Denmark

2

Australia

2

Poland

2

Ukraine

2

Israel

2

Cyprus

2

Mexico

2

Japan

2

South Africa

2

Russia

2

ME

2

Iceland

2

Canada

2

New Zealand

2

Taiwan, Province of China

1

Estonia

1

RS

1

Malaysia

1

Saudi Arabia

1

Luxembourg

1

Slovakia

1

Uruguay

1

Hungary

1

Belgium

1

Bulgaria

1

Croatia

1

Czech Republic

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic